# Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age

> **NCT00814710** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 360 (actual)

## Conditions studied

- Infections, Streptococcal
- Streptococcus Pneumoniae

## Interventions

- **BIOLOGICAL:** Pneumococcal conjugate vaccine GSK1024850A
- **BIOLOGICAL:** Tritanrix-HepB/Hib
- **BIOLOGICAL:** Hiberix
- **BIOLOGICAL:** Tritanrix-HepB

## Key facts

- **NCT ID:** NCT00814710
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-07
- **Primary completion:** 2009-11-13
- **Final completion:** 2009-11-13
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2020-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814710, "Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00814710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*